SMARTag™ ADC technology enables biologic innovators to develop more efficacious antibody drug conjugates. This new platform leverages Catalent’s biologic drug development expertise, advanced GPEx® expression system, analytical services, clinical supply, clinical biomanufacturing and integrated services, offering a number of advantages to ADC developers.
Catalent. More products. Better treatments. Reliably supplied.™
Every molecule has a challenge.
We have a solution.
Call: +1 888 SOLUTION
Email: solutions@catalent.com
Visit: catalent.com
